Danny Burstein in ‘Fiddler on the Roof'(Photo: Joan Marcus) Danny Burstein Show Closed This production ended its run on Dec. 31, 2016 Tevye’s Broadway dream is over. After receiving three 2016 Tony nods but no wins, the fifth Great White Way revival of Fiddler on the Roof, starring Danny Burstein, is set to shutter on December 31. At time of closing the production will have played 34 previews and 464 regular performances. Directed by Bartlett Sher, the classic musical officially opened on December 20, 2015 at the Broadway Theatre.Based on the stories of Sholom Aleichem, Fiddler on the Roof takes place in Anatevka, a village in Tsarist Russia during the eve of the revolution. Tevye (Burstein) is a poor milkman who cares for his five daughters. While he and the rest of the elders in the village are deeply routed in tradition, his daughters’ forward thinking clashes with Tevye’s principles and causes a rift in the family. The musical features a book by Joseph Stein and a score by Jerry Bock and Sheldon Harnick that features the songs “Matchmaker, Matchmaker,” “If I Were A Rich Man” and “Sunrise, Sunset.”The cast also includes Jessica Hecht, Jenny Rose Baker, Michael C. Bernardi, Adam Dannheisser, Hayley Feinstein, Mitch Greenberg, Adam Grupper, Adam Kantor, Karl Kenzler, Alix Korey, Jesse Kovarsky, Samantha Massell, Melanie Moore, George Psomas, Ben Rappaport, Nick Rehberger, Jeffrey Schecter, Alexandra Silber, Jessica Vosk, Lori Wilner, Aaron Young and Jennifer Zetlan.Broadway.com customers with tickets to canceled performances will be contacted with information on refunds or exchanges. View Comments Fiddler on the Roof Related Shows Star Files
On August 31, the Peruvian Government approved the creation of a Special Fund for Citizen Security with a contribution of 200 million soles (70 million dollars) to strengthen the fight against crime, Cabinet chief Salomón Lerner announced. “All of us Peruvians have to unite in this fight for citizen security,” Lerner urged, speaking at the Government palace at the end of a session of the Council of Ministers at which the fund was given the green light. Lerner indicated that the Government will contribute 200 million soles to launch the fund, and he called on the private sector to collaborate with the initiative financially as well. “We are expecting very significant contributions from the private sector that will be made public in the next few days,” noted Lerner, a businessman who is President Ollanta Humala’s right-hand man. The fund seeks to provide the police with radios, patrol cars, and other equipment with which to confront the increase in crime in Peru. At the beginning of August, Humala created a National Council for Citizen Security, chaired by himself, that is developing a plan for joint action to fight crime. The rise of organized crime in recent years, especially kidnapping, is perceived as one of the serious problems affecting Peruvian society, surveys indicate. By Dialogo September 06, 2011
By Voice of America / Edited by Diálogo Staff December 02, 2019 Venezuelan State-owned oil company PDVSA has reduced production and exports since the U.S. government-imposed sanctions. The company, however, has managed to keep some of its main clients with the help of Russian oil company Rosneft, which has become the main trader of PDVSA’s oil.Claudio Loser, former director of the International Monetary Fund’s Western Hemisphere Department, said that Rosneft “is the intermediary,” highlighting its importance in Venezuela’s crude oil sales strategy.In July, direct oil imports from Venezuela to China and India fell sharply, — 40 and 20 percent respectively. At the same time, Russian oil company Rosneft increased its purchase and became the main consumer of Venezuelan oil, taking 66 percent of the country’s oil exports in August, according to news agency Reuters.“Rosneft can buy oil from Venezuela and say we consume this and sell the rest to other countries,” Loser said.Loser told Voice of America that Rosneft’s intermediation has enabled PDVSA to keep some of its traditional clients in China and India, who fear becoming the targets of U.S. sanctions.Lisa Viscidi, director of the Inter-American Dialogue’s Energy, Climate Change and Extractive Industries Program, said that it’s difficult to trace the operations involving Venezuelan oil. “They are trying to conceal the transactions. For instance, it’s been reported that ships navigate without lights so satellites can’t catch them,” Viscidi said in an interview with Voice of America’s Venezuela 360 program.Although PDVSA has been able to maintain some of its exports, Viscidi said that crude oil production in October could plummet further if the U.S. government doesn’t renew permits for U.S. companies that operate oil wells in Venezuela in partnership with PDVSA. Chevron, the most important of these companies, is involved in the production of 181,000 barrels a day.“If Chevron has to leave the country, things will get more complicated for Venezuela, because in general, the projects that do best, those with the most production, are operated by foreign companies,” Viscidi said.According to Loser, the exit of PDVSA’s U.S. partners from Venezuela would greatly impact the influx of Venezuelan migrants in the region. “Obviously, this will affect the government’s capability to grant subsidies. This would have a direct impact on Venezuelans’ tendency to emigrate,” Loser said.Viscidi and Loser agree that PDVSA’s oil production won’t disappear completely, but they believe it is entering a survival stage.“That’s what we saw in Iran; they will continue to export at much lower levels than before,” Loser said.Until 1999, Venezuelan oil accounted for 72 percent of the country’s exports, but in recent years as the nation’s industrial sector collapsed, oil dependency increased 90 percent, paradoxically with the lowest production levels since 1940.
continue reading » ShareShareSharePrintMailGooglePinterestDiggRedditStumbleuponDeliciousBufferTumblr The term “pre-funding” is not interchangeable between defined benefit pension plan pre-funding and overall employee benefits pre-funding. They’re different tools, and credit unions with defined benefit pension plans can gain advantages from using both forms of pre-funding simultaneously.Read on to learn how credit unions use both types of pre-funding. But first, here are some very basic definitions:Employee benefits pre-funding. To help meet overall employee benefits expenses—including health insurance, retirement plans, supplemental executive compensation, etc.—you can use certain investments that credit unions otherwise aren’t permitted to use.For example, the National Credit Union Association and many state regulations allow credit unions to pre-fund employee benefits with corporate bonds, securities, life insurance products and other instruments that fall outside of those allowed by the Code of Federal Regulations, Part 703 (or in some circumstances, Part 704).
Nov 4, 2009 (CIDRAP News) – The head of the Centers for Disease Control and Prevention (CDC) predicted today that the current wave of H1N1 influenza is likely to begin to wane before the shortage of vaccine for it eases.Dr. Thomas Frieden made the comment at a wide-ranging US House subcommittee session that aired the reasons for and impact of the vaccine delays and the prospects for avoiding a repeat of the problem. The session was streamed over the Web.”It’s likely that the current wave of infection will peak, crest, and begin to decline before there are ample supplies,” Frieden told the House Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies. “Whether there’ll be another wave of H1N1 between now and May and whether we’ll get a different strain, only time will tell.”In a similar vein, an Alabama health official said there may not be enough vaccine doses to immunize people outside the priority groups until late December. He and other officials said the vaccine shortage has hurt the credibility of public health at all levels.In other comments, federal health officials described the slow growth of the vaccine virus as the fundamental reason for the current vaccine shortage and suggested that vaccine production difficulties are likely to continue as long as the process relies on growing actual flu viruses, as opposed to producing specific viral proteins.’Virus seems to be winning’Rep. David Obey, D-Wis., chair of the subcommittee, voiced frustration over the vaccine shortage and said the same kinds of problems in flu vaccine production were discussed back in 2004 and 2005. In opening the session, he said the nation has made significant strides since the pandemic virus emerged, “but despite some successes, the virus seems to be winning.”In a brief update on the H1N1 situation, Frieden said the nation has now had “many, many millions of cases” of the illness, well over 20,000 hospitalizations, and more than 1,000 deaths, including 114 children.He asserted that the illness “is no more severe than seasonal flu” but affects a different pattern of age-groups, as more than 90% of deaths are in people younger than 65—a sharp contrast to the seasonal virus.As for the vaccine supply, Frieden said, “With 20-20 hindsight it’s clear we should have been more skeptical” about projections of production timing.Dr. Nicole Lurie, Department of Health and Human Services (HHS) assistant secretary for preparedness and response, said the cumulative vaccine production today reached 32.4 million doses. Despite repeated questions by the committee, she and Frieden firmly refused to make any new predictions about the flow of vaccine.”To be quite honest, flu is really unpredictable, and we’re very hesitant about projecting forward more than week to week, largely because anything could happen,” said Lurie.Shortage’s impact on states and localitiesDr. Donald Williamson, Alabama’s state health officer, said the vaccine shortage has forced Alabama to change its H1N1 vaccination strategy.In September Alabama officials were told they could expect to get about 800,000 doses of vaccine by the end of October, but by Oct 23 the estimated amount was cut to about 400,000 doses, Williamson reported.”Current projections show that 62% of the vaccine coming to Alabama won’t be available until after December 1,” he said. Further, it may not be possible to expand the vaccine to all Alabamans who want it until late December or January.Because of the shortfall, the state decided to focus its vaccination efforts on the subpriority groups identified by the CDC and the providers most likely to serve them, rather than the broader priority groups. (The subpriority groups are pregnant women, healthcare workers, children 6 months through 4 years old, caregivers of babies under 6 months, and children between 5 and 18 with health conditions that put them at risk.)In line with the strategy switch, school-based vaccination clinics have been postponed until late November or early December, Williamson said.Rob Fulton, director of the St. Paul–Ramsey County Public Health Department in Minnesota, told the committee, “We know that the credibility of the entire public health system is in question because of the slow arrival of vaccine.”Like Williamson, he said the slow flow of doses is disrupting vaccination plans. For example, he said the county is anticipating getting 7,800 doses for school children age 9 and under, but the actual population in this age-group is 20,000. (Two doses of vaccine are recommended for children under age 10.)Fulton also commented that 135 of his department’s 320 employees are involved in the H1N1 response at least part-time, which means they have less time to spend on their regular work.Williamson said the vaccine shortage not only undermines public health’s credibility, but also leads people to question the vaccine’s safety. He also voiced concern about the public’s willingness to get the immunization later in the season when supplies finally improve.Root of the problemIn discussion about the cause of the vaccine delays, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), said the basic problem was the slow growth of the vaccine virus in eggs, in combination with the timing of the epidemic.The virus emerged in April, about 3 months later than planning for seasonal flu vaccine normally begins, he said. Then the virus never went away in the summer and was waiting when children went back to school, sparking an epidemic much earlier in the fall than usual, he added.”You have flu waiting for you when the kids go back to school and you have a slow grower, that’s the answer,” Fauci said.Obey asked if the need to provide some vaccine free of thimerosal, a mercury-containing preservative, contributed to the vaccine delays. Thimerosal-free vaccine is produced in individual syringes; putting vaccine in multidose vials is faster but requires thimerosal.Fauci said production of thimerosal-free vaccine probably contributed “a bit” to delays, but was not the major issue. “The fundamental basic problem is the virus not growing well,” he said.Lurie said one of the steps HHS has taken to speed production was to ask the manufacturers to shift production to multidose vials as much as possible.She acknowledged that HHS so far has ordered the filling and finishing of only 117 million of the total 250 million doses of bulk vaccine it has contracted for. “This week we’ve issued orders for more vaccine [to be filled and finished] so we don’t have a gap,” she said. “That 117 million has taken us further into the year than we thought it would.”Lurie said the agency is using a staged approach to filling and finishing because it doesn’t want to have a lot of leftover finished vaccine. “It’s better to keep it in bulk form so it could be used in the seasonal campaign next year or could be used potentially in the developing world.”Fauci asserted that the vaccine makers are not to blame for the vaccine delays. “I don’t want anyone to get the impression that it’s the drug companies’ fault this has happened,” he said. “It’s just the nature of the biology of the virus that it created an expectation that there’d be a certain amount.”The ‘end game’ for vaccine technologyFederal officials were questioned about the use of cell-based methods to make flu vaccines, as is now done to some extent in Europe. Cell-based production is considered more flexible and reliable and somewhat faster than the 1950s method of growing the vaccine virus in chicken eggs.Lurie noted that a cell-based vaccine plant is being built by Novartis in North Carolina and is expected to be ready to start making vaccine in 2011. But how soon a cell-based flu vaccine will win Food and Drug Administration approval is uncertain, she added.The Novartis plant “will get us a little shy of halfway to what our pandemic goal will be,” to make enough vaccine for the entire population, she said.Fauci said cell-based technology will be an improvement but is not the final answer to flu vaccine production problems. “We want to take vaccinology into the 21st century by not requiring the virus to grow. . . . The end game is to get away from requiring the virus to grow.”He said a number of newer approaches involve making particular viral proteins instead of growing the whole virus. One example is using baculovirus, an insect virus, to make the gene for hemagglutinin. He said one company is conducting phase 3 trials of a vaccine using that technique.”What we’re going to see over the next years is a gradual transition from egg-based [vaccine] to egg-based with cell-based to advanced molecular technology,” Fauci predicted.But the ultimate goal, he said, is to make a universal flu vaccine—one that targets a component of the flu virus that doesn’t change from season to season. Such a vaccine could be made and stored in large quantities, and people wouldn’t have to be vaccinated every year.”That’s the plan. That’s going to take years,” he said.
Doctors have taken samples of their bodily fluids to be tested again. The results were likewise expected on Friday afternoon, the spokesperson said.The government planned to continue tracing people suspected of having been in contact with the first two confirmed patients in order to prevent the emergence of new subclusters.”So, from the Jakarta cluster, it is very possible that there will be subclusters. The four people suspected [of having COVID-19] belong to different groups. From the dancing group, they went home and came into contact with their other groups. We’re tracing [these groups]. Hopefully we can trace them all,” he said.Yurianto said the ministry would observe the 10 people identified to be part of the Jakarta cluster. He claimed the 10 people did not complain of any symptoms related to COVID-19, but the ministry would continue observing them to ensure there had been no transmission.Indonesia had tested 227 samples from people as of Thursday evening. Of the total number of samples tested, two were found to be positive, 13 were still awaiting results, with their providers in isolation at various hospitals, while the rest came out negative. (ars)Topics : The four people, Yurianto said, were currently being observed at a hospital, adding that samples of their bodily fluids had been tested at the ministry’s laboratory. The results were expected on Friday afternoon.“Their conditions are stable. Some of them suffer from cough and flu. Some also have a body temperature higher than 37 [degrees Celsius], […] meaning that they have a fever,” said Yurianto, who also serves as the spokesperson for the management of the virus outbreak.Meanwhile, he added that cases 1 and 2, who are undergoing treatment in isolation at the Sulianti Saroso Infectious Disease Hospital, were also in stable condition, although they still suffered from bouts of coughing. Read also: We should thank Indonesia’s COVID-19 ‘Case 1’ instead of breaching her privacy The Health Ministry has identified four individuals suspected of having been infected by the COVID-19 coronavirus after the ministry traced as many as 25 people who had contact with the country’s first two confirmed cases.The ministry’s disease control and prevention directorate general secretary, Achmad Yurianto, said during a press briefing on Friday at noon that the four people had been in close contact with two confirmed patients, known as Case 1 and Case 2.They attended the same dance as Case 1 in mid-February in Jakarta. Case 1 contracted the virus from a Japanese woman who tested positive in Malaysia in late February.
Rebels in South Sudan want foreign oil firms to leave the Upper Nile region immediately.On Tuesday evening, the Sudan People’s Liberation Movement in opposition and allied groups under former Vice President Riek Machar said the firms should leave the Upper Nile region immediately.This is after they said that they have captured a refinery near major oil field in Upper Nile state.However the government has not responded to the reports.“In response to the government’s full scale offensive on our positions in the three states of greater Upper Nile region, we have decided to take control of the oilfields and … (prevent) Salva Kiir from using the oil revenues to perpetuate the war,” James Gatdet Dak, the rebels’ spokesman said.“SPLM/SPLA leadership has asked all oil companies operating in Upper Nile state to shut down their operations and evacuate their staff immediately. We also ask them to do the process of closing down in a safe manner that will not damage the oil facilities and cause environmental damage.”Oil firms in South Sudan include China National Petroleum Corp, India’s ONGC Videsh and Malaysia’s Petronas.Forces loyal to Kiir and rebels allied with his former deputy, Riek Machar, have been fighting for nearly 18 months in the world’s newest state, which seceded from Sudan in 2011.SPLA-in-Opposition spokesman, James Gatdet Dak, said that the rebels were still fighting government troops in the area that is home to South Sudan’s biggest oilfield – Paloch.Forces loyal to Kiir and rebels allied with his former deputy, Riek Machar, have been fighting for nearly 18 months in the world’s newest state, which seceded from Sudan in 2011.Several ceasefires have been reached and broken and each side accuses the other of violating one announced in February.
Promoted ContentBest & Worst Celebrity Endorsed Games Ever MadeCan Playing Too Many Video Games Hurt Your Body?A Hurricane Can Be As Powerful As 10 Atomic BombsWhich Country Is The Most Romantic In The World?You’ve Only Seen Such Colorful Hairdos In A Handful Of Anime11 Strange Facts About Your Favorite TV ShowsWho Is The Most Powerful Woman On Earth?Best Car Manufacturers In The WorldThe Very Last Bitcoin Will Be Mined Around 2140. Read More11 Most Immersive Game To Play On Your Table Top7 Ways To Understand Your Girlfriend Better7 Universities In The World Where Education Costs Too Much When Manchester City meet Real Madrid in the Champions League on Wednesday night, a striker who played for both clubs will be celebrating his 36th birthday on the either side of the Atlantic. He was a hero in his new land before he had even kicked a ball. Paraguay is a relatively poor country with a population of 7 million which is entirely unused to having global stars on parade in its domestic league. The great Ferenc Puskas had a spell coaching in the country in the mid 80s, but to have a player of Adebayor’s CV in the local championship is a genuine novelty. He arrived in the country in the wee small hours a couple of weeks ago – and thousands had gone out to the airport to greet him. He nearly became even more of a hero in his debut on Sunday. It was the day of Paraguay’s traditional big derby, Olimpia against Cerro Porteno. Still working on his fitness, Adebayor started the game on the bench. But at half-time his old Manchester City team-mate Roque Santa Cruz felt a twinge and was taken off as a precaution. On came the man from Togo in the No25 shirt. He looked to keep things simple, playing first time whenever he could. He won a number of flick-ons in the air, and in stoppage time, with the score at 1-1, he was just a few inches away from snatching the winner, glancing a cross from the right just wide of the near post. Loading… Emmanuel Adebayor arrived to a hero’s welcome at Olimpia and will want to add the Copa Libertadores to his glittering CV All in all it was an encouraging start. True, it was disappointing not to win the historic local derby. But then Olimpia’s sights are set well beyond the frontiers of Paraguay. Next week the group phase gets underway in the Copa Libertadores, South America’s version of the Champions League. Olimpia are serious players. They have won the trophy three times, though not since 2002. But they are always competitive, reaching the final in 2013 only to lose on penalties, and getting through to the last 16 in 2019. This year they are dreaming of going further. They hope to count on the traditional Paraguayan virtues of defensive resilience, with a back line organised by former Premier League centre back Antolin Alcaraz. When he left Olimpia to join Bayern Munich back in 1999 the Germans truly believed they had signed a player destined for a place on the podium in the annual FIFA awards. Were it not for all those injuries, it may have happened. But fit and enjoying his football, he rolled back the years in the last few months of 2019. And now Olimpia have the option of pairing him with Adebayor or rotating them in the centre forward position. Others have come in, too. International winger Derlis Gonzalez should prove a good foil and supply line for the big guns. Argentine central midfielder Nico Domingo is adept at dictating play from deep. Olimpia’s group in the Libertadores looks straightforward enough. Santos of Brazil are operating on a low budget. Argentine debutants Defensa y Justicia sold so many players that their coach resigned. Ex-Chelsea striker Hernan Crespo has stepped in. And Ecuadorian champions Delfin are novices at the level. Read Also:Paraguay’s Olimpia Asuncion sign Emmanuel Adebayor Olimpia, then, are entitled to aim high. Long after either Man City or Real Madrid have been eliminated, Emmanuel Adebayor will have his sights set on glory in a continental competition. FacebookTwitterWhatsAppEmail分享
Versailles, In. — Following a two-day jury trial Curtis Gridley, 41, of Batesville, has been found guilty of attempted manufacturing of methamphetamine and theft with a prior conviction. Sentencing has been scheduled for April 30. Gridley could receive a sentence of up to 12 years in prison.The investigation began in December of 2016 when Gridley purchased or took items consistent with manufacturing drugs from three Batesville businesses. One of Gridley’s family members told police he was with Gridley when he made chemical purchases from Kroger and CVS and took a pipe cutting tool from Gillman Do it Best Home Center. Detectives confirmed the theft through surveillance footage from the store.Witnesses from Gillman’s Do It Best, Ripley County Sheriff’s Department and the Indiana State Police Methamphetamine Suppression Unit testified during the proceedings.
Promoted ContentTop 10 TV Friends Who Used To Be Enemies10 Risky Jobs Some Women DoTop 10 Most Famous Female Racers Of All TimeWhy Do So Many Digital Assistants Have Feminine Names & Voices?The Highest Paid Football Players In The World11 Most Immersive Game To Play On Your Table Top6 Most Breathtaking Bridges In The WorldTop 10 TV Characters Meant To Be IconicTop 10 Most Romantic Nations In The World6 Extreme Facts About Hurricanes5 Of The World’s Most Unique Theme ParksEver Thought Of Sleeping Next To Celebs? This Guy Will Show You Loading… “For sure, I have no doubt. He is a player who will show a lot of energy on the pitch. He is very good tactically, good with the ball, and good without the ball. He is a fantastic signing for us. read also:Everton boss Ancelotti targets Lazio striker “He is going to put strength in midfield. This is his best quality. For this reason, all the players we have with quality are going to improve for being with him. He is not just a player for himself. He is a player whose energy can make others better. “He’s very aggressive. Defensively, he is really good. My personal opinion is that he is one of the best defensive midfielders in the world. He is intelligent tactically and he has got a lot of energy. One against one, he is really strong.” FacebookTwitterWhatsAppEmail分享 Everton manager, Carlo Ancelotti, has lavished praise on new signing Allan. The Brazilian is a combative defensive midfielder who has established himself as one of the best in Europe with Napoli. Ancelotti has managed him before, and now will get the chance to release Allan on the Premier League. The 29-year-old signed a three year deal with the Toffees on Saturday. “[I am] happy for this,” Ancelotti told reporters. “I think that it was not easy to find a deal but, in the end, we were able to do it and I think he will prove to be a fantastic player for us with quality and ability.Advertisement